CTOs on the Move

KickApps

www.kickapps.com

 
KickApps provides brands, enterprises and web publishers with solutions that enable them to create and manage next generation web experiences that are social, interactive, dynamic, distributed, and data-informed.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

HyperMedia Communications

HyperMedia Communications is a Bryan, TX-based company in the Software and Internet sector.

Knowledge Coop

The Knowledge Coop is an online training and social networking site to help mortgage professionals be compliant. In your company`s online coop aka virtual workspace, you can provide training with tracking and reporting, get policy help from your peers and other compliance professionals, and get tough questions answered on a range of topics.

WebRecon

Industry leading suite of tools to isolate consumer accounts that file lawsuits against collection agencies, creditors and debt collectors and other businesses.

BUFFERZONE Security

BUFFERZONEs advanced endpoint security solution features: • Container: A secure, virtual environment for accessing content from any potentially risky source including internet browsers, removable media and e-mail. • Bridge: A configurable process...

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.